{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T20:51:57Z","timestamp":1754599917246},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[1992,11,1]],"date-time":"1992-11-01T00:00:00Z","timestamp":720576000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur. J. Clin. Microbiol. Infect. Dis."],"published-print":{"date-parts":[[1992,11]]},"DOI":"10.1007\/bf01967790","type":"journal-article","created":{"date-parts":[[2005,7,30]],"date-time":"2005-07-30T07:50:43Z","timestamp":1122709843000},"page":"999-1011","source":"Crossref","is-referenced-by-count":9,"title":["Current antimicrobial therapy of anaerobic infections"],"prefix":"10.1007","volume":"11","author":[{"given":"C. V.","family":"Sanders","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. E.","family":"Aldridge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01967790_CR1","first-page":"332","volume":"3","author":"SM Finegold","year":"1984","unstructured":"Finegold SM Increasing resistance in anaerobes. Infections in Surgery 1984, 3: 332\u2013336.","journal-title":"Infections in Surgery"},{"issue":"Supplement 5","key":"BF01967790_CR2","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/clinids\/8.Supplement_5.S543","volume":"8","author":"CE Nord","year":"1986","unstructured":"Nord CE Mechanisms of \u03b2-lactam resistance in anaerobic bacteria. Reviews of Infectious Diseases 1986, 8, Supplement 5: 543\u2013548.","journal-title":"Reviews of Infectious Diseases"},{"key":"BF01967790_CR3","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/0003-9969(80)90102-8","volume":"25","author":"A Heimdahl","year":"1980","unstructured":"Heimdahl A, von Konow L, Nord CE Isolation of \u03b2-lactamase-producingBacteroides strains associated with clinical failures with penicillin treatment of human orofacial infections. Archives of Oral Biology 1980, 25: 689\u2013692.","journal-title":"Archives of Oral Biology"},{"key":"BF01967790_CR4","doi-asserted-by":"crossref","first-page":"466","DOI":"10.7326\/0003-4819-98-4-466","volume":"98","author":"ME Levison","year":"1983","unstructured":"Levison ME, Mangura CT, Lorber B, Abrutyn E, Pesanti E, Levy RS, Macgregor RR, Schwartz AR Clindamycin compared with penicillin for the treatment of anaerobic lung abscess. Annals of Internal Medicine 1983, 98: 466\u2013471.","journal-title":"Annals of Internal Medicine"},{"key":"BF01967790_CR5","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1001\/archinte.1990.00390230077010","volume":"150","author":"F Gudiol","year":"1990","unstructured":"Gudiol F, Manresa F, Pallares R, Dorca J, Rufi G, Boada J, Ariza X, Casanova A, Viladrich PF Clindamycin versus penicillin for anaerobic lung infections: high rate of penicillin failures associated with penicillin-resistantBacteroides melaninogenicus. Archives of Internal Medicine 1990, 150: 2525\u20132529.","journal-title":"Archives of Internal Medicine"},{"key":"BF01967790_CR6","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1128\/AAC.10.4.736","volume":"10","author":"VL Sutter","year":"1976","unstructured":"Sutter VL, Finegold SM Susceptibility of anaerobic bacteria to 23 antimicrobial agents. Antimicrobial Agents and Chemotherapy 1976, 10: 736\u2013752.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01967790_CR7","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1128\/AAC.34.3.479","volume":"34","author":"GJ Cuchural","year":"1990","unstructured":"Cuchural GJ, Tally FP, Jacobus NV Comparative activities of newer \u03b2-lactam agents against members of theBacteroides fragilis group. Antimicrobial Agents and Chemotherapy 1990, 34: 479\u2013480.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01967790_CR8","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1128\/AAC.14.1.105","volume":"14","author":"ML Britz","year":"1978","unstructured":"Britz ML, Wilkinson RG Chloramphenicol acetyltransferase ofBacteroides fragilis. Antimicrobial Agents and Chemotherapy 1978, 14: 105\u2013111.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01967790_CR9","first-page":"273","volume":"5","author":"KE Aldridge","year":"1988","unstructured":"Aldridge KE, Henderberg A, Schiro DD, Sanders CV Susceptibility ofBacteroides fragilis group isolates to broad-spectrum \u03b2-lactams, clindamycin, and metronidazole: rates of resistance, cross-resistance, and importance of \u03b2-lactamase production. Advances in Therapy 1988, 5: 273\u2013282.","journal-title":"Advances in Therapy"},{"key":"BF01967790_CR10","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/S0140-6736(83)92494-7","volume":"i","author":"MS Sprott","year":"1983","unstructured":"Sprott MS, Ingham HR, Hickman JE, Sisson PR Metronidazole-resistant anaerobes. Lancet 1983, i: 1220.","journal-title":"Lancet"},{"key":"BF01967790_CR11","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/jac\/18.5.642","volume":"18","author":"F Lamothe","year":"1986","unstructured":"Lamothe F, Fijalkowski C, Malouin F, Bourgault AM, Delorme L Bacteroides fragilis resistant to both metronidazole and imipenem. Journal of Antimicrobial Chemotherapy 1986, 18: 642\u2013643.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF01967790_CR12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0147-619X(89)90060-7","volume":"21","author":"J Breuil","year":"1989","unstructured":"Breuil J, Dublanchet A, Truffaut N, Sebald M Transferable 5-nitroimidazole resistance in theBacteroides fragilis group. Plasmid 1989, 21: 151\u2013154.","journal-title":"Plasmid"},{"key":"BF01967790_CR13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/jac\/27.1.63","volume":"27","author":"E Nagy","year":"1991","unstructured":"Nagy E, Foldes J Inactivation of metronidazole byEnterococcus faecalis. Journal of Antimicrobial Chemotherapy 1991, 27: 63\u201370.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF01967790_CR14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1001\/archsurg.1992.01420010097015","volume":"127","author":"JMA Bohnen","year":"1992","unstructured":"Bohnen JMA, Solomkin JS, Dellinger EP, Bjornson HS, Page CP Guidelines for clinical care: anti-infective agents for intra-abdominal infection. A Surgical Infection Society policy statement. Archives of Surgery 1992, 127: 83\u201389.","journal-title":"Archives of Surgery"},{"key":"BF01967790_CR15","first-page":"221","volume":"93","author":"Canadian Metronidazole-Clindamycin Study Group","year":"1983","unstructured":"Canadian Metronidazole-Clindamycin Study Group Prospective, randomized comparison of metronidazole and clindamycin, each with gentamicin, for the treatment of serious intra-abdominal infection. Surgery 1983, 93: 221\u2013229.","journal-title":"Surgery"},{"key":"BF01967790_CR16","series-title":"International Congress and Symposium Series no. 18, Royal Society of Medicine","volume-title":"The use of metronidazole in the treatment of anaerobic pleuropulmonary infections","author":"CV Sanders","year":"1979","unstructured":"Sanders CV, Hanna BJ, Lewis AC, Scalcini M The use of metronidazole in the treatment of anaerobic pleuropulmonary infections. Proceedings of the 2nd International Symposium on Anaerobic Infections, Geneva, 1979. International Congress and Symposium Series no. 18, Royal Society of Medicine. Grune & Stratton, New York, 1979."},{"key":"BF01967790_CR17","first-page":"337","volume":"120","author":"CV Sanders","year":"1979","unstructured":"Sanders CV, Hanna BJ, Lewis AC Metronidazole in the treatment of anaerobic infections. American Review of Respiratory Disease 1979, 120: 337\u2013343.","journal-title":"American Review of Respiratory Disease"},{"key":"BF01967790_CR18","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1001\/archinte.1981.00340120032009","volume":"141","author":"CA Perlino","year":"1981","unstructured":"Perlino CA Metronidazole versus clindamycin treatment of anaerobic pulmonary infection: failure of metronidazole therapy. Archives of Internal Medicine 1981, 141: 1424\u20131427.","journal-title":"Archives of Internal Medicine"},{"key":"BF01967790_CR19","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1128\/AAC.30.5.645","volume":"30","author":"GJ Cuchural","year":"1986","unstructured":"Cuchural GJ, Malamy MH, Tally FP \u03b2-lactamase-mediated imipenem resistance inBacteroides fragilis. Antimicrobial Agents and Chemotherapy 1986, 30: 645\u2013648.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01967790_CR20","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1128\/AAC.35.2.371","volume":"35","author":"K Bandoh","year":"1991","unstructured":"Bandoh K, Muto Y, Watanabe R, Katoh N, Ueno K Biochemical properties and purification of metallo-\u03b2-lactamase fromBacteroides fragilis. Antimicrobials Agents and Chemotherapy 1991, 35: 371\u2013372.","journal-title":"Antimicrobials Agents and Chemotherapy"},{"key":"BF01967790_CR21","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1128\/AAC.18.2.220","volume":"18","author":"B Olsson-Liljequist","year":"1980","unstructured":"Olsson-Liljequist B, Dornbusch K, Nord CE Characterization of three different \u03b2-lactamases from theBacteroides fragilis group. Antimicrobial Agents and Chemotherapy 1980, 18: 220\u2013225.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01967790_CR22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/jac\/19.2.143","volume":"19","author":"HM Wexler","year":"1987","unstructured":"Wexler HM, Finegold SM Antimicrobial resistance inBacteroides. Journal of Antimicrobial Chemotherapy 1987, 19: 143\u2013146.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF01967790_CR23","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jac\/19.2.161","volume":"19","author":"LJV Piddock","year":"1987","unstructured":"Piddock LJV, Wise R Cefoxitin resistance inBacteroides species: evidence indicating two mechanisms causing decreased susceptibility. Journal of Antimicrobial Chemotherapy 1987, 19: 161\u2013170.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF01967790_CR24","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1128\/AAC.32.5.611","volume":"32","author":"SM Finegold","year":"1988","unstructured":"Finegold SM, Wexler HM Therapeutic implications of bacteriologic findings in mixed aerobic-anaerobic infections. Antimicrobial Agents and Chemotherapy 1988, 32: 611\u2013616.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01967790_CR25","first-page":"715","volume":"154","author":"GL Drusano","year":"1982","unstructured":"Drusano GL, Warren JW, Saah AJ, Caplan ES, Tenney JH, Hansen S, Granados J, Standiford HC, Miller EH A prospective randomized controlled trial of cefoxitin versus clindamycin-aminoglycoside in mixed anaerobic-aerobic infections. Surgery, Gynecology, and Obstetrics 1982, 154: 715\u2013720.","journal-title":"Surgery, Gynecology, and Obstetrics"},{"key":"BF01967790_CR26","first-page":"648","volume":"98","author":"MA Malangoni","year":"1985","unstructured":"Malangoni MA, Condon RE, Spiegel CA Treatment of intraabdominal infections is appropriate with single-agent or combination antibiotic therapy. Surgery 1985, 98: 648\u2013655.","journal-title":"Surgery"},{"key":"BF01967790_CR27","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1128\/AAC.26.3.410","volume":"26","author":"KE Aldridge","year":"1984","unstructured":"Aldridge KE, Sanders CV, Janney A, Faro S, Marier RL Comparison of the activities of penicillin G and new \u03b2-lactam antibiotics against clinical isolates ofBacteroides species. Antimicrobial Agents and Chemotherapy 1984, 26: 410\u2013413.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01967790_CR28","doi-asserted-by":"crossref","first-page":"642","DOI":"10.7326\/0003-4819-108-4-643_1","volume":"108","author":"A Conjura","year":"1988","unstructured":"Conjura A, Bell W, Lipsky JJ Cefotetan and hypoprothrombinemia. Annals of Internal Medicine 1988, 108: 642.","journal-title":"Annals of Internal Medicine"},{"key":"BF01967790_CR29","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0002-9610(88)80214-9","volume":"155","author":"RL Sweet","year":"1988","unstructured":"Sweet RL, Gall SA, Gibbs RS, Hemsell DL, Knuppel RA, Lane TW, Miller RD, Newton ER, Poindexter AN, Reguero W, Spence M, Tischler SH Multicenter clinical trials comparing cefotetan with moxalactam or cefoxitin as therapy for obstetric and gynecologic infections. American Journal of Surgery 1988, 155: 56\u201360.","journal-title":"American Journal of Surgery"},{"key":"BF01967790_CR30","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S0002-9378(16)44535-7","volume":"158","author":"DL Hemsell","year":"1988","unstructured":"Hemsell DL, Wendel GD, Gall SA, Newton ER, Gibbs RS, Knuppel RA, Lane TW, Sweet RL Multicenter comparison of cefotetan and cefoxitin in the treatment of acute obstetric and gynecologic infections. American Journal of Obstetrics and Gynecology 1988, 158 (Part 2): 722\u2013727.","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"BF01967790_CR31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0002-9610(88)80215-0","volume":"155","author":"SE Wilson","year":"1988","unstructured":"Wilson SE, Boswick JA, Duma RJ, Echols RM, Jemsek JG, Lerner R, Lewis RT, Najem AZ, Press RA, Rittenbury MS, Stone HH, Ton GT Cephalosporin therapy in intraabdominal infections. A multicenter randomized, comparative study of cefotetan, moxalactam, and cefoxitin. American Journal of Surgery 1988, 155: 61\u201366.","journal-title":"American Journal of Surgery"},{"key":"BF01967790_CR32","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0002-9610(88)80222-8","volume":"155","author":"A Sochalski","year":"1988","unstructured":"Sochalski A, Sullman S, Andriole VT Cost-effectiveness study of cefotetan versus cefoxitin and cefotetan versus combination antibiotic regimens. American Journal of Surgery 1988, 155: 96\u2013101.","journal-title":"American Journal of Surgery"},{"key":"BF01967790_CR33","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0002-9610(88)80224-1","volume":"155","author":"M Barza","year":"1988","unstructured":"Barza M Cefotetan: summary of the symposium from an internist's viewpoint. American Journal of Surgery 1988, 155: 103\u2013107.","journal-title":"American Journal of Surgery"},{"key":"BF01967790_CR34","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0002-9610(88)80225-3","volume":"155","author":"DE Fry","year":"1988","unstructured":"Fry DE Cefotetan: a perspective for the surgical patient. American Journal of Surgery 1988, 155: 108\u2013110.","journal-title":"American Journal of Surgery"},{"key":"BF01967790_CR35","first-page":"72","volume":"37","author":"RE Condon","year":"1990","unstructured":"Condon RE The role of cefmetazole in surgery. Contemporary Surgery 1990, 37: 72\u201382.","journal-title":"Contemporary Surgery"},{"issue":"Supplement D","key":"BF01967790_CR36","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/jac\/23.suppl_D.131","volume":"23","author":"A Saito","year":"1989","unstructured":"Saito A Cefmetazole postmarketing surveillance in Japan. Journal of Antimicrobial Chemotherapy 1989, 23, Supplement D: 131\u2013139.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF01967790_CR37","unstructured":"Cefmetazole sodium (Zefazone). The Medical Letter 1990, 32, issue 822."},{"key":"BF01967790_CR38","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/0002-9610(82)90594-3","volume":"144","author":"TV Berne","year":"1982","unstructured":"Berne TV, Yellin AW, Appleman MD, Heseltine PNR Antibiotic management of surgically treated gangrenous or perforated appendicitis. American Journal of Surgery 1982, 144: 8\u201313.","journal-title":"American Journal of Surgery"},{"issue":"Supplement","key":"BF01967790_CR39","first-page":"47","volume":"2","author":"KE Aldridge","year":"1984","unstructured":"Aldridge KE, Sanders CV, Marier RL In vitro synergy and potentiation between cefotaxime and desacetyl-cefotaxime against clinical isolates ofBacteroides. Diagnostic Microbiology and Infectious Disease 1984, 2, Supplement: 47\u201353.","journal-title":"Diagnostic Microbiology and Infectious Disease"},{"issue":"Supplement A","key":"BF01967790_CR40","first-page":"12","volume":"10","author":"HM Wexler","year":"1987","unstructured":"Wexler HM, Finegold SM In vitro activity of selected antibiotics against anaerobes. clinical Therapeutics 1987, 10, Supplement A: 12\u201318.","journal-title":"clinical Therapeutics"},{"key":"BF01967790_CR41","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1128\/JCM.25.12.2317-2321.1987","volume":"25","author":"KE Aldridge","year":"1987","unstructured":"Aldridge KE, Sanders CV Antibiotic and method-dependent variation in susceptibility testing results ofBacteroides fragilis group isolates. Journal of Clinical Microbiology 1987, 25: 2317\u20132321.","journal-title":"Journal of Clinical Microbiology"},{"key":"BF01967790_CR42","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1128\/AAC.34.1.179","volume":"34","author":"KE Aldridge","year":"1990","unstructured":"Aldridge KE, Wexler HM, Sanders CV, Finegold SM Comparison of in vitro antibiograms ofBacteroides fragilis group isolates: differences in resistance rates in two institutions because of differences in susceptibility testing methodology. Antimicrobial Agents and Chemotherapy 1990, 34: 179\u2013181.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"Supplement","key":"BF01967790_CR43","first-page":"64","volume":"7","author":"DN Gerding","year":"1988","unstructured":"Gerding DN Therapy of lower extremity infections in patients with diabetes mellitus and\/or peripheral vascular disease. Infections in Surgery 1988, 7, Supplement: 64\u201368.","journal-title":"Infections in Surgery"},{"issue":"Supplement","key":"BF01967790_CR44","first-page":"57","volume":"7","author":"MA Lou","year":"1988","unstructured":"Lou MA Comparative evaluation of ceftizoxime and cefoxitin in the treatment of traumatic bacterial peritonitis. Infections in Surgery 1988, 7, Supplement: 57\u201363.","journal-title":"Infections in Surgery"},{"issue":"Supplement C","key":"BF01967790_CR45","first-page":"31","volume":"12","author":"RS Bennion","year":"1990","unstructured":"Bennion RS, Thompson JE, Baron EJ, Finegold SM Gangrenous and perforated appendicitis with peritonitis: treatment and bacteriology. Clinical Therapeutics 1990, 12, Supplement C: 31\u201344.","journal-title":"Clinical Therapeutics"},{"issue":"Supplement","key":"BF01967790_CR46","first-page":"51","volume":"7","author":"JS Solomkin","year":"1988","unstructured":"Solomkin JS Ceftizoxime versus tobramycin plus clindamycin for intraabdominal infections. Infections in Surgery 1988, 7, Supplement: 51\u201356.","journal-title":"Infections in Surgery"},{"key":"BF01967790_CR47","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/infdis\/142.3.384","volume":"142","author":"GKM Harding","year":"1980","unstructured":"Harding GKM, Buckwold JF, Ronald AR, Marrie TJ, Brunton S, Koss JC, Gurwith MJ, Albritton WL Prospective randomized comparative study of clindamycin, chloramphenicol, and ticarcillin, each in combination with gentamicin, in therapy for intraabdominal and female tract sepsis. Journal of Infectious Diseases 1980, 142: 384\u2013393.","journal-title":"Journal of Infectious Diseases"},{"key":"BF01967790_CR48","first-page":"995","volume":"42","author":"S Faro","year":"1987","unstructured":"Faro S, Pastorek JG, Aldridge KE, Martens M, Phillips LE, Nicaud S, Cunningham G Piperacillin versus clindamycin plus gentamicin in the treatment of postpartum endometritis. Current Therapeutic Research 1987, 42: 995\u20131002.","journal-title":"Current Therapeutic Research"},{"key":"BF01967790_CR49","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/jac\/17.4.463","volume":"17","author":"KE Aldridge","year":"1986","unstructured":"Aldridge KE, Sanders CV, Marier RL Variation in the potentiation of \u03b2-lactam antibiotic activity by clavulanic acid and sulbactam against multiply antibiotic-resistant bacteria. Journal of Antimicrobial Chemotherapy 1986, 17: 463\u2013469.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF01967790_CR50","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1128\/JCM.26.6.1246-1247.1988","volume":"26","author":"PC Fuchs","year":"1988","unstructured":"Fuchs PC, Barry AL, Jones RN Evaluation of in vitro methods for testing susceptibility of anaerobes to ampicillin-sulbactam and amoxicillin-clavulanic acid. Journal of Clinical Microbiology 1988, 26: 1246\u20131247.","journal-title":"Journal of Clinical Microbiology"},{"key":"BF01967790_CR51","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-4362.1987.tb00544.x","volume":"26","author":"EJC Goldstein","year":"1987","unstructured":"Goldstein EJC, Reinhardt JF, Murray PM, Finegold SM Outpatient therapy of bite wounds: demographic data, bacteriology and a prospective randomized trial of amoxicillin\/clavulanic acid versus penicillin \u00b1 dicloxacillin. International Journal of Dermatology 1987, 26: 123\u2013127.","journal-title":"International Journal of Dermatology"},{"key":"BF01967790_CR52","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1128\/AAC.25.3.392","volume":"25","author":"PC Fuchs","year":"1984","unstructured":"Fuchs PC, Barry AL, Thornsberry C, Jones RN In vitro activity of ticarcillin plus clavulanic acid against 632 clinical isolates. Antimicrobial Agents and Chemotherapy 1984, 25: 392\u2013394.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01967790_CR53","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0732-8893(88)90060-0","volume":"9","author":"PC Fuchs","year":"1988","unstructured":"Fuchs PC, Jones RN, Barry AL, Allen SD, Aldridge KE, Gerlach EH, Sommers HM Effect of clavulanic acid on the susceptibility of clinical anaerobic bacteria to ticarcillin: a multicenter study. Diagnostic Microbiology and Infectious Disease 1988, 9: 47\u201350.","journal-title":"Diagnostic Microbiology and Infectious Disease"},{"key":"BF01967790_CR54","first-page":"60","volume-title":"Prevention of infection following penetrating abdominal trauma","author":"TC Fabian","year":"1987","unstructured":"Fabian TC Prevention of infection following penetrating abdominal trauma. Proceedings of a symposium on new approaches to antimicrobial therapy, Tucson, AZ, 1987. Wallace Communications, Princeton, NJ, 1987, p. 60\u201361."},{"key":"BF01967790_CR55","first-page":"56","volume-title":"Ticarcillin\/clavulanic acid in the treatment of soft tissue pelvic infections","author":"S Faro","year":"1987","unstructured":"Faro S, Phillips LE, Martens MG, Smith DN, Goodrich KH, Riddle GD, Turner RM Ticarcillin\/clavulanic acid in the treatment of soft tissue pelvic infections. Proceedings of a symposium on new approaches to antimicrobial therapy, Tuscon, AZ, 1987. Wallace Communications, Princeton, NJ, 1987, p. 56\u201359."},{"key":"BF01967790_CR56","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/jac\/24.suppl_B.147","volume":"24","author":"MP Fink","year":"1989","unstructured":"Fink MP, Helsmoortel CM, Arous EJ, Doern GV, Moriarty KP, Fairchild PG, Townsend PL Comparison of the safety and efficacy of parenteral ticarcillin\/clavulanate and clindamycin\/gentamicin in serious intraabdominal infections. Journal of Antimicrobial Chemotherapy 1989, 24: 147\u2013156.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"Supplement","key":"BF01967790_CR57","first-page":"30","volume":"172","author":"KR Sirinek","year":"1991","unstructured":"Sirinek KR, Levine BA A randomized trial of ticarcillin and clavulanate versus gentamicin and clindamycin in patients with complicated appendicitis. Surgery, Gynecology, and Obstetrics 1991, 172, Supplement: 30\u201335.","journal-title":"Surgery, Gynecology, and Obstetrics"},{"issue":"Supplement 5","key":"BF01967790_CR58","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/clinids\/8.Supplement_5.S528","volume":"8","author":"JA Retsema","year":"1986","unstructured":"Retsema JA, English AR, Girard A, Lynch JE, Anderson M, Brennan L, Cimochowski C, Faiella J, Norcia W, Sawyer P Sulbactam\/ampicillin: in vitro spectrum, potency, and activity in models of acute infection. Reviews of Infectious Diseases 1986, 8, Supplement 5: 528\u2013534.","journal-title":"Reviews of Infectious Diseases"},{"issue":"Supplement A","key":"BF01967790_CR59","first-page":"15","volume":"23","author":"HM Wexler","year":"1988","unstructured":"Wexler HM, Harris B, Carter WT, Finegold SM In vitro efficacy of sulbactam combined with ampicillin against anaerobic bacteria. Hospital Formulary 1988, 23, Supplement A: 15\u201317.","journal-title":"Hospital Formulary"},{"issue":"Supplement A","key":"BF01967790_CR60","first-page":"18","volume":"23","author":"BV Stromberg","year":"1988","unstructured":"Stromberg BV, Reines D, Hunt P Comparative clinical study of sulbactam-ampicillin and clindamycintobramycin in infections of soft tissues. Hospital Formulary 1988, 23, Supplement A: 18\u201322.","journal-title":"Hospital Formulary"},{"issue":"Supplement A","key":"BF01967790_CR61","first-page":"23","volume":"23","author":"WR Cromblehome","year":"1988","unstructured":"Cromblehome WR, Ohm-Smith M, Robbie MO, DeKay V, Sweet RL Ampicillin\/sulbactam versus metronidazole-gentamicin in the treatment of soft tissue pelvic infections. Hospital Formulary 1988, 23, Supplement A: 23\u201329.","journal-title":"Hospital Formulary"},{"issue":"Supplement 5","key":"BF01967790_CR62","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/clinids\/8.Supplement_5.S583","volume":"8","author":"Study Group of Intraabdominal Infections","year":"1986","unstructured":"Study Group of Intraabdominal Infections A randomized controlled trial of ampicillin plus sulbactam versus gentamicin plus clindamycin in the treatment of intraabdominal infections: a preliminary report. Reviews of Infectious Disease 1986, 8 Supplement 5: 583\u2013588.","journal-title":"Reviews of Infectious Disease"},{"key":"BF01967790_CR63","first-page":"303","volume":"161","author":"AE Yellin","year":"1985","unstructured":"Yellin AE, Heseltine PNR, Berne TV, Appleman MD, Gill MA, Riggio CE, Chenella FC The role ofPseudomonas species in patients treated with ampicillin and sulbactam for gangrenous and performated appendicitis. Surgery, Gynecology, and Obstetrics 1985, 161: 303\u2013307.","journal-title":"Surgery, Gynecology, and Obstetrics"},{"key":"BF01967790_CR64","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0732-8893(89)90113-2","volume":"12","author":"MS Gelfand","year":"1989","unstructured":"Gelfand MS, Grogan JT, Haas MJ In vitro comparison of cefoperazone\/sulbactam with selected antimicrobials against 300Bacteroides isolates: inhibitory activity and time-kill kinetic studies. Diagnostic Microbiology and Infectious Disease 1989, 12: 421\u2013428.","journal-title":"Diagnostic Microbiology and Infectious Disease"},{"key":"BF01967790_CR65","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/jac\/29.1.57","volume":"29","author":"RB Clark","year":"1992","unstructured":"Clark RB, Bartelt MA, Chan EL, Dalton HP Multicenter study on antibiotic susceptibilities of anaerobic bacteria to cefoperazone-sulbactam and other antimicrobial agents. Journal of Antimicrobial Chemotherapy 1992, 29: 57\u201367.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF01967790_CR66","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/jac\/25.3.423","volume":"25","author":"LE Jauregui","year":"1990","unstructured":"Jauregui LE, Appelbaum PC, Fabian TC, Hageage G, Strausbaugh L, Martin LF A randomized clinical study of cefoperazone and sulbactam versus gentamicin and clindamycin in the treatment of intraabdominal infections. Journal of Antimicrobial Chemotherapy 1990, 25: 423\u2013433.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF01967790_CR67","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1128\/AAC.33.11.1964","volume":"33","author":"NA Kuck","year":"1989","unstructured":"Kuck NA, Jacobus NV, Petersen PJ, Weiss WJ, Testa RT Comparative in vitro and in vivo activities of piperacillin combined with the \u03b2-lactamase inhibitors tazobactam, clavulanic acid, and sulbactam. Antimicrobial Agents and Chemotherapy 1989, 33: 1964\u20131969.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01967790_CR68","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1128\/AAC.33.8.1268","volume":"33","author":"Rj Fass","year":"1989","unstructured":"Fass Rj, Prior RB comparative in vitro activities of piperacillin-tazobactam and ticarcillin-clavulanate. Antimicrobial Agents and Chemotherapy 1989, 33: 1268\u20131274.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01967790_CR69","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1128\/AAC.35.6.1219","volume":"35","author":"HM Wexler","year":"1991","unstructured":"Wexler HM, Molitoris E, Finegold SM Effect of \u03b2-lactamase inhibitors on the activities of various \u03b2-lactam agents against anaerobic bacteria. Antimicrobial Agents and Chemotherapy 1991, 35: 1219\u20131224.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01967790_CR70","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0732-8893(89)90083-7","volume":"12","author":"RN Jones","year":"1989","unstructured":"Jones RN, Pfaller MA, Fuchs PC, Aldridge K, Allen SD, Gerlach EH Piperacillin\/tazobactam (YTR 830) combination. Diagnostic Microbiology of Infectious Disease 1989, 12: 489\u2013494.","journal-title":"Diagnostic Microbiology of Infectious Disease"},{"key":"BF01967790_CR71","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1128\/AAC.33.9.1580","volume":"33","author":"K Coleman","year":"1989","unstructured":"Coleman K, Griffin DRJ, Page JWJ, Upshon PA In vitro evaluation of BRL 42715, a novel \u03b2-lactamase inhibitor. Antimicrobial Agents and Chemotherapy 1989, 33: 1580\u20131587.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"Supplement 6A","key":"BF01967790_CR72","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0002-9343(85)90097-X","volume":"78","author":"J Birnbaum","year":"1985","unstructured":"Birnbaum J, Kahan FM, Kropp H, MacDonald JS Carbapenems, a new class of beta-lactam antibiotics. Discovery and development of imipenem\/cilastatin. American Journal of Medicine 1985, 78, Supplement 6A: 3\u201321.","journal-title":"American Journal of Medicine"},{"issue":"Supplement 3","key":"BF01967790_CR73","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/clinids\/7.Supplement_3.S389","volume":"7","author":"H Kropp","year":"1985","unstructured":"Kropp H, Gerckens L, Sundelof JG, Kahan FM Antibacterial activity of imipenem: the first thienamycin antibiotic. Reviews of Infectious Diseases 1985, 7, Supplement 3: 389\u2013410.","journal-title":"Reviews of Infectious Diseases"},{"key":"BF01967790_CR74","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1001\/archsurg.1988.01400270056008","volume":"123","author":"AW Hackford","year":"1988","unstructured":"Hackford AW, Tally FP, Reinhold RB, Barza M, Gorbach SL Prospective study comparing imipenem-cilastatin with clindamycin and gentamicin for the treatment of serious surgical infections. Archives of Surgery 1988, 123: 322\u2013326.","journal-title":"Archives of Surgery"},{"key":"BF01967790_CR75","first-page":"43","volume":"162","author":"PNR Heseltine","year":"1986","unstructured":"Heseltine PNR, Yellin AE, Appleman MD, Gill MA, Chenella FC, Berne TV, Leedom JM Imipenem therapy for perforated and gangrenous appendicitis. Surgery 1986, 162: 43\u201348.","journal-title":"Surgery"},{"key":"BF01967790_CR76","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00000658-198703000-00009","volume":"205","author":"HR Gonzenbach","year":"1987","unstructured":"Gonzenbach HR, Simmen HP, Amgwerd R Imipenem (N-F-thienamycin) versus netilmicin plus clindamycin: a controlled and randomized comparison in intraabdominal infections. Annals of Surgery 1987, 205: 271\u2013275.","journal-title":"Annals of Surgery"},{"issue":"Supplement 6A","key":"BF01967790_CR77","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0002-9343(85)90106-8","volume":"78","author":"JS Solomkin","year":"1985","unstructured":"Solomkin JS, Fant WK, Rivera JO, Alexander JW Randomized trial of imipenem\/cilastatin versus gentamicin and clindamycin in mixed flora infections. American Journal of Medicine 1985, 78, Supplement 6A: 85\u201391.","journal-title":"American Journal of Medicine"},{"key":"BF01967790_CR78","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/00000658-199011000-00004","volume":"212","author":"JS Solomkin","year":"1990","unstructured":"Solomkin JS, Dellinger EP, Christou NV, Busuttil RW Results of a multicenter trial comparing imipenem\/cilastatin to tobramycin\/clindamycin for intraabdominal infections. Annals of Surgery 1990, 212: 581\u2013591.","journal-title":"Annals of Surgery"},{"key":"BF01967790_CR79","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/0002-9343(88)90071-X","volume":"84","author":"G Calandra","year":"1988","unstructured":"Calandra G, Lydick E, Carrigan J, Weiss L, Guess H Factors predisposing to seizures in seriously ill infected patients receiving antibiotics: experience with imipenem\/cilastatin. American Journal of Medicine 1988, 84: 911\u2013918.","journal-title":"American Journal of Medicine"},{"issue":"Supplement A","key":"BF01967790_CR80","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/jac\/24.suppl_A.9","volume":"24","author":"RN Jones","year":"1989","unstructured":"Jones RN, Barry AL, Thornsberry C In vitro studies of meropenem. Journal of Antimicrobial Chemotherapy 1989, 24, Supplement A: 9\u201329.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF01967790_CR81","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0732-8893(90)90055-Z","volume":"13","author":"PR Murray","year":"1990","unstructured":"Murray PR, Niles AC In vitro activity of meropenem (SM-7338), imipenem, and five other antibiotics against anaerobic clinical isolates. Diagnostic Microbiology and Infectious Disease 1990, 13: 57\u201361.","journal-title":"Diagnostic Microbiology and Infectious Disease"},{"key":"BF01967790_CR82","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1128\/AAC.36.1.239","volume":"36","author":"HM Wexler","year":"1992","unstructured":"Wexler HM, Molitoris E, Finegold SM In vitro activities of three of the newer quinolones against anaerobic bacteria. Antimicrobial Agents and Chemotherapy 1992, 36: 239\u2013243.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01967790_CR83","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1128\/AAC.34.9.1858","volume":"34","author":"RA Venezia","year":"1990","unstructured":"Venezia RA, Yocum DM, Robbiano EM, Echols RM Comparative in vitro activities of a new quinolone, WIN 57273, and piperacillin plus tazobactam against anaerobic bacteria. Antimicrobial Agents and Chemotherapy 1990, 34: 1858\u20131861.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01967790_CR84","first-page":"1828","volume-title":"Principles and practice of infectious diseases","author":"JG Bartlett","year":"1990","unstructured":"Bartlett JG Anaerobic bacteria: general concepts. In: Mandell GL, Douglas RG, Bennett JE (ed): Principles and practice of infectious diseases. Churchill Livingstone, New York, 1990, p. 1828\u20131870."},{"key":"BF01967790_CR85","first-page":"1860","volume-title":"Principles and practice of infectious diseases","author":"DF Zaleznik","year":"1990","unstructured":"Zaleznik DF, Kasper DL Bacteroides species. In: Mandell GL, Douglas RG, Bennett JE (ed): Principles and practice of infectious diseases. Churchill Livingstone, New York, 1990, p. 1860\u20131870."},{"issue":"Supplement","key":"BF01967790_CR86","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0732-8893(89)90123-5","volume":"12","author":"SM Finegold","year":"1989","unstructured":"Finegold SM Mechanisms of resistance in anaerobes and new developments in testing. Diagnostic Microbiology and Infectious Disease 1989, 12, Supplement: 117\u2013120.","journal-title":"Diagnostic Microbiology and Infectious Disease"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01967790.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01967790\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01967790","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T12:39:51Z","timestamp":1586349591000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01967790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,11]]},"references-count":86,"journal-issue":{"issue":"11","published-print":{"date-parts":[[1992,11]]}},"alternative-id":["BF01967790"],"URL":"https:\/\/doi.org\/10.1007\/bf01967790","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,11]]}}}